Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes

Published:2016-08-25 Issue:11 Volume:39 Page:2036-2041
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:Dia Care

Author:

Daniele Giuseppe,Xiong Juan,Solis-Herrera Carolina,Merovci Aurora,Eldor Roy,Tripathy Devjit,DeFronzo Ralph A.,Norton Luke,Abdul-Ghani Muhammad

Funder

National Institutes of Health

Publisher

American Diabetes Association

Subject

Advanced and Specialised Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference30 articles.

1. Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes

2. Dapagliflozin for the treatment of type 2 diabetes

3. Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production

4. Dapagliflozin Lowers Plasma Glucose Concentration and Improves β-Cell Function

5. Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Adaptation in Heart Failure and the Role of Ketone Bodies as Biomarkers;Current Heart Failure Reports;2024-09-07

2. Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials;The Lancet Diabetes & Endocrinology;2024-09

3. Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial;The Lancet Diabetes & Endocrinology;2024-09

4. Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction;JAMA;2024-08-06

5. Dapagliflozin attenuates fat accumulation and insulin resistance in obese mice with polycystic ovary syndrome;European Journal of Pharmacology;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3